PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Byannli authorised in Britain for schizophrenia treatment

Market authorisation for twice-yearly schizophrenia treatment which offers patients much-needed medication continuity The Medicines and Healthcare products Regula...
Continue Reading →
News

Second COVID-19 antiviral set for release

Vulnerable people at risk from COVID-19 are set to have access to game-changing Pfizer antiviral The UK’s second ground-breaking antiviral–Pfizer’s Paxlovid (rito...
Continue Reading →
News

CHMP approves Dupixent for young children with asthma

Positive news for children aged six to 11 as Dupixent offers improved asthma treatment The Committee for Medicinal Products for Human Use (CHMP) has recommended D...
Continue Reading →
News

Gene genies: Oxford Biomedica and Homology Medicines create AAV business

Leading gene and cell therapy group, Oxford Biomedica, and Homology Medicines, have announced that the companies will establish a high-performing Adeno-Associated Vi...
Continue Reading →
News

Injection of optimism as HIV vaccine trial begins

The first doses of an experimental HIV vaccine have been delivered in the phase 1 clinical trial. International AIDS Vaccine Initiative (IAVI), a non-profit scientif...
Continue Reading →
News

Innovative phase 2 trial targets advanced liver cancer

The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second-line standard of care sorafenib versus the use of sorafenib in isola...
Continue Reading →
News

Access to Novartis treatment for Myeloid leukaemia patients

Novartis UK has announced that the MHRA has given a positive scientific opinion for the investigational treatment, asciminib Consequently, adult patients with chr...
Continue Reading →
News

Training begins for psychedelic-assisted clinical trial

Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines. As interest in psyched...
Continue Reading →
News

Enrol call: Verona recruits 800 patients for COPD trial

The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed with COPD. Verona Pharma ha...
Continue Reading →
News

Scandi pharma: Swede deal for Psyros Diagnostics

Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology en...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026